doses for tirzepatide compound Dosing Weight Loss in Units Why does compounded tirzepatide have

Who Should Avoid or Delay GLP-1 Therapy Certain medical conditions require caution or contraindicate GLP-1 use

Medical Conditions and Medications Interfering with GLP-1 Certain medical conditions reduce your body's ability to respond to GLP-1 therapy

Wegovy and Ozempic are both injectable medications that contain the same active ingredient semaglutide

As the first approved dual agonist targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor, it achieves glycemic control and weight loss outcomes that exceed those of selective GLP-1 receptor agonists alone